Evidence map›Paper›PMID 38662700›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

District-Level Forecast of Achieving Trachoma Elimination as a Public Health Problem By 2030: An Ensemble Modelling Approach.

Ariktha Srivathsan, Amza Abdou, Tawfik Al-Khatib, Sue-Chen Apadinuwe, Mouctar D Badiane, Victor Bucumi, Tina Chisenga, George Kabona, Martin Kabore, Sarjo Kebba Kanyi and 27 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Trachoma.Lancet (London, England) · 2025
    Review
  6. Trachoma in Croatia: How Did it Become a Thing of the Past?Medical archives (Sarajevo, Bosnia and Herzegovina) · 2025
    Review
  7. New Tools and Nuanced Interventions to Accelerate Achievement of the 2030 Roadmap for Neglected Tropical Diseases.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 19 institutions in 18 countries.

Ariktha SrivathsanFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
Amza AbdouProgramme National de Santé Oculaire, Ministère De La Santé Publique, Niamey, Niger.
Tawfik Al-KhatibPrevention of Blindness Program, Ministry of Public Health & Population, Sana'a, Yemen.
Sue-Chen ApadinuweMinistry of Health and Medical Services, Denig, Republic of Nauru.
Mouctar D BadianeProgramme National de Promotion de La Santé Oculaire, Ministère de la Santé et de L'Action sociale, Dakar, Sénégal.
Victor BucumiDépartement En Charge des Maladies Tropicales Négligées, Ministère De La Santé Publique Et De La Lutte Contre Le Sida, Bujumbura, Burundi.
Tina ChisengaMinistry of Health Public Health Department, Lusaka, Zambia.
George KabonaNeglected Tropical Disease Control Program, Ministry of Health and Social Welfare, Dar Es Salaam, United Republic of Tanzania.
Martin KaboreProgramme national de lutte contre les maladies tropicales négligées, Ministère de la santé et de l'hygiène publique, Ouagadougou, Burkina Faso.
Sarjo Kebba KanyiThe National Eye Health Programme, Ministry of Health and Social Welfare, Banjul, Kanifing, The Gambia.
Lucienne BellaProgramme National De Lutte Contre La Cécité, Ministère De La Santé Publique, Yaoundé, Cameroon.
Nekoua M'poProgramme National De Lutte Contre Les Maladies Transmissibles, Ministère De La Santé, Cotonou, Benin.
Michael MasikaDepartment of Clinical Services, Ministry of Health, Lilongwe, Malawi.
Abdellahi MinnihDépartement Des Maladies Transmissibles, Ministère De La Santé Nouakchott, Nouakchott, Mauritania.
Henis Mior SitoeDirecção Nacional De Saúde Pública Ministerio Da Saude, Maputo, Mozambique.
Sailesh MishraNepal Netra Jyoti Sangh, Kathmandu, Nepal.
Nicholas OlobioNational Trachoma Elimination Programme, Federal Ministry of Health, Abuja, Nigeria.
Fatma Juma OmarZanzibar Ministry of Health, Zanzibar Town, Zanzibar.
Isaac PhiriDepartment of Epidemiology and Disease Control, Ministry of Health & Child Welfare, Harare, Zimbabwe.
Salimato SanhaPrograma Nacional De Saúde De Visão, Minsap, Bissau, Guinea-Bissau.
Fikre SeifeFederal Ministry of Health, Addis Ababa, Ethiopia.
Shekhar SharmaNepal Netra Jyoti Sangh, Kathmandu, Nepal.
Rabebe TekeraoiEye Department, Ministry of Health and Medical Services, South Tarawa, Kiribati.
Lamine TraoreProgramme National de la Santé Oculaire, Ministère de la Santé, Bamako, Mali.
Titus WatituMinistry of Health, Nairobi, Kenya.
Yak Yak BolNeglected Tropical Diseases Programme, Ministry of Health, Juba, South Sudan.
Anna BorlaseDepartment of Biology, University of Oxford, Oxford, United Kingdom.
Michael S DeinerFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
Kristen K RennekerInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, USA.
P J HooperInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, USA.
Paul M EmersonInternational Trachoma Initiative, The Task Force for Global Health, Decatur, Georgia, USA.
Andreia VasconcelosBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Benjamin F ArnoldFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
Travis C PorcoFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
T Déirdre HollingsworthBig Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Thomas M LietmanFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
Seth BlumbergFrancis I. Proctor Foundation, University of California, San Francisco, California, USA.
University of California, San Francisco · USThe Task Force for Global Health · USUniversity of Oxford · GBFederal Ministry of Health · ETFederal Ministry of Health · NGInstituto Nacional de Saúde · MZMinistère De La Santé · BFMinistère de la Santé Publique · NEMinistère de la Santé Publique · BIMinistry of Fisheries and Marine Resource Development · KIMinistry of Health · ZMMinistry of Health · KEMinistry of Health · MWMinistry of Health and Child Welfare · ZWMinistry of Health and Social Welfare · TZMinistry of Health and Social Welfare · GMSana'a University · YEUniversity of Juba · SSUniversity of Nouakchott Al Aasriya · MR

Funding

Forecasting Trachoma Control - Diversity SupplementR01EY025350 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI THOMAS M LIETMAN, Travis Christian Porco · 2016 to 2026
$3.3M
Modeling the dynamics of disease eliminationR35GM147702 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Seth Blumberg · 2022 to 2026
$2.0M
NEI NIH HHS R01 EY025350NIGMS NIH HHS R35 GM147702
6 · The paper itself

Abstract

Assessing the feasibility of 2030 as a target date for global elimination of trachoma, and identification of districts that may require enhanced treatment to meet World Health Organization (WHO) elimination criteria by this date are key challenges in operational planning for trachoma programmes. Here we address these challenges by prospectively evaluating forecasting models of trachomatous inflammation-follicular (TF) prevalence, leveraging ensemble-based approaches. Seven candidate probabilistic models were developed to forecast district-wise TF prevalence in 11 760 districts, trained using district-level data on the population prevalence of TF in children aged 1-9 years from 2004 to 2022. Geographical location, history of mass drug administration treatment, and previously measured prevalence data were included in these models as key predictors. The best-performing models were included in an ensemble, using weights derived from their relative likelihood scores. To incorporate the inherent stochasticity of disease transmission and challenges of population-level surveillance, we forecasted probability distributions for the TF prevalence in each geographic district, rather than predicting a single value. Based on our probabilistic forecasts, 1.46% (95% confidence interval [CI]: 1.43-1.48%) of all districts in trachoma-endemic countries, equivalent to 172 districts, will exceed the 5% TF control threshold in 2030 with the current interventions. Global elimination of trachoma as a public health problem by 2030 may require enhanced intervention and/or surveillance of high-risk districts.

Indexed as

Disease EradicationForecastingPublic HealthTrachomaChildChild, PreschoolFemaleGlobal HealthHumansInfantMaleMass Drug AdministrationModels, StatisticalPrevalenceWorld Health Organization

Identifiers

PMID38662700
PMCPMC11045026
OpenAlexW4395466365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.